Cargando…

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports

BACKGROUND: Adverse drug reaction (ADR) is a major burden for patients and healthcare industry. Early and accurate detection of potential ADRs can help to improve drug safety and reduce financial costs. Post-market spontaneous reports of ADRs remain a cornerstone of pharmacovigilance and a series of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ruoqi, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918608/ https://www.ncbi.nlm.nih.gov/pubmed/31849321 http://dx.doi.org/10.1186/s12911-019-0999-1

Ejemplares similares

An Early Adverse Drug Event Detection Approach with False Discovery Rate Control
por: Shi, Yi, et al.
Publicado: (2023)

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan
por: Uhara, H., et al.
Publicado: (2017)

The Detection of Adverse Drug Reactions
por: Crooks, James
Publicado: (1977)

Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
por: Soldatos, Theodoros G., et al.
Publicado: (2022)

Adverse Drug Reaction Related Post Detecting Using Sentiment Feature
por: LIU, Jingfang, et al.
Publicado: (2018)

Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
por: Maity, Tuhin, et al.
Publicado: (2021)

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
por: Onakpoya, Igho J., et al.
Publicado: (2016)

Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
por: Alomar, Muaed, et al.
Publicado: (2020)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
por: Apte, Aditi Anand
Publicado: (2016)

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
por: Wakabayashi, Tomohito, et al.
Publicado: (2022)

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
por: Li, Ying, et al.
Publicado: (2020)

A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs
por: Sutherland, Jeffrey J., et al.
Publicado: (2023)

Adverse Drug Reactions. Their Prediction, Detection and Assessment
Publicado: (1973)

Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
por: Xu, Rong, et al.
Publicado: (2014)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2016)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

iADRs: towards online adverse drug reaction analysis
por: Lin, Wen-Yang, et al.
Publicado: (2012)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Predicting potential adverse events using safety data from marketed drugs
por: Daluwatte, Chathuri, et al.
Publicado: (2020)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2019)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Textbook of adverse drug reactions /
Publicado: (1977)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse drug reactions in the elderly
por: Brahma, Dhriti K., et al.
Publicado: (2013)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Textbook of Adverse Drug Reactions
por: George, Charles F.
Publicado: (1992)

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system
por: Jiang, Tingting, et al.
Publicado: (2022)

A comparative analysis of adverse drug reactions: pre- and post regional pharmacovigilance center in a single tertiary hospital
por: Nam, Young-Hee, et al.
Publicado: (2015)

Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions
por: Hashiguchi, Masayuki, et al.
Publicado: (2015)

Explainable detection of adverse drug reaction with imbalanced data distribution
por: Wang, Jin, et al.
Publicado: (2022)

Adverse drug reactions of nonsteroidal anti-inflammatory drugs
por: Wiwanitkit, Viroj
Publicado: (2011)

Adverse drug reactions induced by cardiovascular drugs in outpatients
por: Gholami, Kheirollah, et al.
Publicado: (2008)

First reports of adverse drug reactions and drug interactions
Publicado: (2022)

First reports of adverse drug reactions and drug interactions
Publicado: (2022)

Comparing drug safety of hepatitis C therapies using post-market data
por: Huang, Jing, et al.
Publicado: (2019)

Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis
por: Hakkarainen, Katja M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lgarhqugr1l9ivo9dg94lem2m0